Butyric Acid ( DrugBank: Butyric Acid )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 222 | Primary nephrotic syndrome | 1 |
222. Primary nephrotic syndrome
Clinical trials : 310 / Drugs : 295 - (DrugBank : 117) / Drug target genes : 63 - Drug target pathways : 194
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2200057174 | 2022-02-20 | 2022-03-02 | Efficacy and safety of glutamine combined with Clostridium butyricum in the treatment of hormone-dependent minor lesion nephropathy | Efficacy and safety of glutamine combined with Clostridium butyricum in the treatment of hormone-dependent minor lesion nephropathy | Primary nephrotic syndrome | Control group:Conventional therapy (steroid+rituximab);Intervention group:Conventional treatment + glutamine + clostridium butyric acid; | Shanghai Children's Hospital | NULL | Pending | 1 | 18 | Both | Control group:49;Intervention group:49; | China |